Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
or
Menu
  • quotes

  • charts

  • technicals

  • company

Benitec Ltd (BNIKF)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (BATS)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTHER OTC]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ fieldTitles[key] ]] [[ value ]] [[ value ]]

Price Performance

See More
Period Period Low Period High Performance
1-Month
0.1440 +0.69%
on 04/12/18
0.1580 -8.23%
on 03/27/18
-0.0150 (-9.38%)
since 03/23/18
3-Month
0.1440 +0.69%
on 04/12/18
0.1900 -23.68%
on 01/26/18
-0.0350 (-19.44%)
since 01/24/18
52-Week
0.0889 +63.10%
on 08/25/17
0.2500 -42.00%
on 01/16/18
+0.0080 (+5.84%)
since 04/24/17

Most Recent Stories

More News
ASX/NASDAQ Announcement

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today provided an update on its two lead programs in head and neck squamous cell carcinoma (HNSCC) and oculopharyngeal muscular dystrophy...

BNIKF : 0.1450 (-4.61%)
Benitec Biopharma Launches its Phase 2 Oncology Study in Australia

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) ("Benitec" or "the Company"), a biotechnology company developing innovative therapeutics based on a combination of gene therapy and its...

BNIKF : 0.1450 (-4.61%)
Federal R&D Tax Credit Received

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) advises that it has received a $4,112,058 cash refund for the year ended 2017 under the Federal Government's R&D Tax Incentive Scheme.

BNIKF : 0.1450 (-4.61%)
Benitec receives U.S. Orphan Drug Designation for BB-301, its ddRNAi therapeutic for the treatment of oculopharyngeal muscular dystrophy

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) today announced that the U.S. Food & Drug Administration (FDA) has granted Orphan Drug Designation to BB-301 for the treatment of oculopharyngeal...

BNIKF : 0.1450 (-4.61%)
Benitec Biopharma provides update on OPMD orphan disease program

Benitec Biopharma Limited (ASX:BLT; NASDAQ:BNTC; NASDAQ:BNTCW) is pleased to announce it has submitted an application with the U.S. Food & Drug Administration (FDA) seeking orphan drug designation for...

BNIKF : 0.1450 (-4.61%)
U.S. patent granted for Benitec hepatitis B program

Benitec Biopharma Limited (ASX:BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce that a new patent relating to the Company's hepatitis B program has been issued in the United States. Titled "HBV...

BNIKF : 0.1450 (-4.61%)
Benitec Biopharma advances OPMD orphan disease program

Benitec Biopharma Limited (ASX: BLT; NASDAQ: BNTC; NASDAQ: BNTCW) is pleased to announce it has developed a new single vector (gene therapy construct) system which uses DNA directed RNA interference (ddRNAi)...

BNIKF : 0.1450 (-4.61%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Sell with a Weakening short term outlook on maintaining the current direction.

Longer term, the trend strength is Minimum.

See More Share

Key Turning Points

2nd Resistance Point 0.1450
1st Resistance Point 0.1450
Last Price 0.1450
1st Support Level 0.1450
2nd Support Level 0.1450

See More

52-Week High 0.2500
Fibonacci 61.8% 0.1885
Fibonacci 50% 0.1694
Fibonacci 38.2% 0.1504
Last Price 0.1450
52-Week Low 0.0889

See More

Add Data Columns to this Table
Learn about our Custom Views
Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
New Chart Menu
Right-click anywhere on the chart to open the Interactive Chart menu.

Free Barchart Webinar